Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors
- PMID: 32687977
- DOI: 10.1016/j.cgh.2020.07.024
Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors
Abstract
Background and aims: Granular mixed laterally spreading tumors (GM-LSTs) have an intermediate level of risk for submucosal invasive cancer (SMICs) without clear signs of invasion (covert); the optimal resection method is uncertain. We aimed to determine the risk of covert SMIC in GM-LSTs based on clinical and endoscopic factors.
Methods: We collected data from 693 patients (50.6% male; median age, 69 years) with colorectal GM-LSTs, without signs of invasion, who underwent endoscopic resection (74.2%) or endoscopic submucosal dissection (25.2%) at 7 centers in Italy from 2016 through 2019. We performed multivariate and univariate analyses to identify demographic and endoscopic factors associated with risk of SMIC. We developed a multivariate model to calculate the number needed to treat (NNT) to detect 1 SMIC.
Results: Based on pathology analysis, 66 patients (9.5%) had covert SMIC. In multivariate analyses, increased risk of covert SMIC were independently associated with increasing lesion size (odds ratio per mm increase, 1.02, 95% CI, 1.01-1.03; P = .003) and rectal location (odds ratio, 3.08; 95% CI, 1.62-5.83; P = .004). A logistic regression model based on lesion size (with a cutoff of 40 mm) and rectal location identified patients with covert SMIC with 47.0% sensitivity, 82.6% specificity, and an area under the curve of 0.69. The NNT to identify 1 patient with a nonrectal SMIC smaller than 4 cm was 20; the NNT to identify 1 patient with a rectal SMIC of 4 cm or more was 5.
Conclusions: In an analysis of data from 693 patients, we found the risk of covert SMIC in patients with GM-LSTs to be approximately 10%. GM-LSTs of 4 cm or more and a rectal location are high risk and should be treated by en-bloc resection. ClinicalTrials.gov, Number: NCT03836131.
Keywords: Colon Cancer; Outcome; Prognostic Factor; Stratification.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
Narrowing the Set of Target Lesions for Colorectal Endoscopic Submucosal Dissection.Clin Gastroenterol Hepatol. 2021 Jul;19(7):1341-1343. doi: 10.1016/j.cgh.2020.09.031. Epub 2020 Sep 19. Clin Gastroenterol Hepatol. 2021. PMID: 32961341 No abstract available.
-
Submucosal Cancer in Granular Mixed Type Laterally Spreading Tumors: Is Universal ESD an Acceptable Approach in These Lesions?Clin Gastroenterol Hepatol. 2021 Aug;19(8):1736. doi: 10.1016/j.cgh.2020.08.035. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248072 No abstract available.
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials